Y
Power Law company profile
Y-mAbs Therapeutics
Biotech & Life Sciences · New York City, United States · Founded 2014 · IPO 2018 Unicorn
Global footprint
Where Y-mAbs Therapeutics has talent and traffic
Web traffic by country
4.3K
monthly visits
across markets
across markets
🇺🇸 United States69.8%
🇮🇳 India30.2%
Patent intelligence
$435k patent portfolio · 8 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$435k
0.13% of valuation · 1792.1× smaller than top peer BioNTech ($780M)
8 active patent families
Where Y-mAbs Therapeutics innovates
Molecular biologyAntigenAntigen Binding FragmentCarcinosisCD33
Tracks the peer median across all five Patsnap quality dimensions.
Quality vs same-sector peers
Y-mAbs Therapeutics on the five Patsnap quality dimensions
Y-mAbs Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Y-mAbs Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Y-mAbs Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Y-mAbs Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.